USPTO serial 88251756
ALFATROL
Reviewed by CopyMark Law Group
Status 605
- Filing date
- Status date
- Registration date
- —
- Examiner
- SNABB, SANDRA MARIE
- Law office
- GENERIC WEB UPDATE
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with ALFATROL?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Veterinary preparations for companion animals, farm animals, dogs, cats, horses, chickens, cattle and pigs for the treatment of Anti-inflammatory, anti-shock, inflammation of digestive system, inflammation of respiratory system, anti-pancreatitis, pulmonary insufficiency, kidney disease, disseminated intravascular coagulation, chronic obstructive pulmonary disease, pyometra, spondylosis deformans, systemic inflammatory response syndrome, pneumonia, infectious peritonitis, sepsis, inhibiting thrombogenesis, allergy, tumor metastasis control, infectious disease, encephalitis and surgical stress; pharmaceutical preparations for skin care for animals; medicines for veterinary purposes for Companion animals, farm animals, dogs, cats, horses, chickens, cattle and pigs for the treatment of Anti-inflammatory, anti-shock, inflammation of digestive system, inflammation of respiratory system, anti-pancreatitis, pulmonary insufficiency, kidney disease, disseminated intravascular coagulation, chronic obstructive pulmonary disease, pyometra, spondylosis deformans, systemic inflammatory response syndrome, pneumonia, infectious peritonitis, sepsis, inhibiting thrombogenesis, allergy, tumor metastasis control, infectious disease, encephalitis and surgical stress | ABANDONED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 15, 2019 | MAB5 | ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION | — |
| Oct 15, 2019 | ABN5 | ABANDONMENT - AFTER PUBLICATION | — |
| Oct 10, 2019 | EXAR | TEAS EXPRESS ABANDONMENT RECEIVED | — |
| Sep 30, 2019 | ALIE | ASSIGNED TO LIE | — |
| Sep 26, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 26, 2019 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Sep 26, 2019 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Sep 26, 2019 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Sep 26, 2019 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Feb 28, 2019 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 28, 2019 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 28, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 21, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 27, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 10, 2019 | NWAP | NEW APPLICATION ENTERED | — |